The kainate receptor family was initially characterized in the 1980s following the identification of kainic acid as a potent neuroexcitant. Kainic acid, extracted from the red alga Diginea simplex, was found to produce seizures in experimental animals and has since been used as a tool to model epileptogenesis. The recognition that specific membrane proteins mediated kainic acid effects led to the identification of the GRIK (GluR/KA) gene family. GRIKBP1 was subsequently identified as a binding protein that modulates these receptor complexes, adding another layer of complexity to glutamate receptor signaling.
GRIKBP1 encodes a binding protein that interacts with kainate-type glutamate receptors. While not a receptor subunit itself, this protein modulates receptor trafficking, localization, and function. Kainate receptors represent a class of ionotropic glutamate receptors that mediate excitatory synaptic transmission and play crucial roles in synaptic plasticity, learning, and memory. Dysfunction of kainate receptors and their associated proteins has been implicated in various neurodegenerative and neuropsychiatric disorders [1].
| Glutamate Ionotropic Receptor Kainate Type Subunit Binding Protein 1 | |
|---|---|
| Gene Symbol | GRIKBP1 |
| Full Name | Glutamate Ionotropic Receptor Kainate Type Subunit Binding Protein 1 |
| Chromosome | 19p13.3 |
| NCBI Gene ID | [55120](https://www.ncbi.nlm.nih.gov/gene/55120) |
| OMIM | 618049 |
| Ensembl ID | ENSG00000166664 |
| UniProt ID | [Q9C0B1](https://www.uniprot.org/uniprot/Q9C0B1) |
| Associated Diseases | [Alzheimer's Disease](/diseases/alzheimers-disease), [Epilepsy](/diseases/epilepsy), Intellectual Disability |
GRIKBP1 is located on chromosome 19p13.3 and encodes a protein that interacts with kainate receptor subunits, particularly those containing the GluK5 (GRIK2) subunit. The protein contains multiple protein-protein interaction domains that facilitate its scaffolding function.
The kainate receptor family consists of five subunits (GluK1-5, formerly GluR5-7, KAR1,2):
GRIKBP1 belongs to a group of proteins that modulate kainate receptor function without forming the core receptor channel. These include:
These auxiliary subunits regulate receptor trafficking to the plasma membrane, kinetics, and pharmacology [2].
GRIKBP1 functions as a scaffold protein that:
Kainate receptors mediate both ionotropic (fast) and metabotropic (slow) synaptic transmission. GRIKBP1 modulates these responses by affecting:
GRIKBP1 is expressed throughout the nervous system:
Expression is developmental, with distinct patterns in different brain regions and at different life stages.
Kainate receptors are increasingly recognized in AD pathophysiology:
Kainate receptors have long been associated with epileptogenesis:
Glutamate release → Kainate receptor activation (with GRIKBP1) → Ca2+ influx →
→ Excitotoxic signaling → Cell death
This pathway is particularly relevant to neurodegenerative diseases where glutamate homeostasis is disrupted.
Kainate receptor activation → PAK1/ERK signaling → Gene expression → Synaptic strengthening
Contractor A, et al. Kainate receptors: function and plasticity. Learning & Memory. 2012. ↩︎
Petzoldt AG, et al. Kainate receptor auxiliary subunits regulate neuronal excitability. Current Opinion in Neurobiology. 2018. ↩︎
Castillo CG, et al. Kainate receptors in Alzheimer's disease and age-related cognitive decline. Ageing Research Reviews. 2019. ↩︎